Xencor reported $18.53M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
AbbVie 2.94B 2.66B Dec/2024
Alnylam Pharmaceuticals USD 102.39M 4.99M Jun/2025
Amgen USD 18.03B 15.63B Jun/2025
Arrowhead Research USD 33.05M 23.07M Jun/2025
AstraZeneca 23.99B 1.44B Jun/2025
Biogen USD 408.4M 16.9M Jun/2025
Bristol-Myers Squibb USD 5.43B 1.42B Jun/2025
Cytokinetics USD 68.54M 54.6M Jun/2025
GlaxoSmithKline 14.82B 329M Jun/2025
J&J USD 9.54B 766M Mar/2025
MacroGenics USD 4.66M 353K Jun/2025
Merck USD 4.04B 261M Jun/2025
Novartis USD 4.51B 245M Jun/2025
Pfizer USD 5.17B 74M Jun/2025
Regeneron Pharmaceuticals USD 723.9M 18.4M Jun/2025
Roche Holding 4.35B 828M Dec/2024
Xencor USD 18.53M 2.34M Jun/2025